These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 545284)

  • 21. [Viral hepatitis type A. Seroepidemiological study in Padova and its district].
    Vendramini R; Fiaschi E; Naccarato R; Chiara-Monte M; Renzulli G; Canazza S; Trivello R
    Boll Ist Sieroter Milan; 1980 Sep; 59(4):338-47. PubMed ID: 6258611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonparenteral transmission of viral hepatitis in Greece.
    Hadziyannis SJ
    Am J Med Sci; 1975; 270(2):313-8. PubMed ID: 1235473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of hepatitis A in Sardinia: prevalence of anti-HAV in a sample of junior and senior high school students].
    Contu P; Uccheddu P; Dodero G; Masia G
    Ann Ig; 1989; 1(5):1119-24. PubMed ID: 2483894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum antibodies against hepatitis A virus among subjects of middle and low socioeconomic levels in urban area of Santiago, Chile].
    Lagos R; Potin M; Muñoz A; Abrego P; San Martín OS; Ureta AM; Bustamante C
    Rev Med Chil; 1999 Apr; 127(4):429-36. PubMed ID: 10451608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seroprevalence of hepatitis A in hospitalized patients in Limoges University Hospital].
    Denis F; Delpeyroux C; Debrock C; Rogez S; Alain S
    Gastroenterol Clin Biol; 2003; 27(8-9):727-31. PubMed ID: 14586245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.
    Dal-Ré R; García-Corbeira P; García-de-Lomas J
    J Med Virol; 2000 Apr; 60(4):363-6. PubMed ID: 10686017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of anti-HAV antibodies in Warsaw population].
    Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
    Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: evidence for infection with a subgenotype IA HAV in children.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Okamoto H
    J Med Virol; 2007 Jan; 79(1):18-25. PubMed ID: 17133554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua.
    Perez OM; Morales W; Paniagua M; Strannegard O
    Am J Trop Med Hyg; 1996 Jul; 55(1):17-21. PubMed ID: 8702016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing epidemiology of hepatitis A virus infection--a comparative study in central eastern Poland (1990-1999).
    Polz-Dacewicz MA; Policzkiewicz P; Badach Z
    Med Sci Monit; 2000; 6(5):989-93. PubMed ID: 11208443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
    Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
    J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
    Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study.
    Sagnelli E; Stroffolini T; Almasio P; Mele A; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Viral Hepat; 2006 Jan; 13(1):67-71. PubMed ID: 16364085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Seroepidemiology of hepatitis A in six departments in West-Central France in 1991].
    Dubois F; Thevenas C; Caces E; Vol S; Doctoriarena A; Ecault JL; Goudeau A; Tichet J
    Gastroenterol Clin Biol; 1992; 16(8-9):674-9. PubMed ID: 1426823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.